Table of Content

1. Preface
? ? 1.1. Market Definition and Scope
? ? 1.2. Market Segmentation
? ? 1.3. Key Research Objectives
? ? 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global HER2 Antibodies Market

4. Market Overview
? ? 4.1. Introduction
? ? ? ? 4.1.1. Product Definition
? ? ? ? 4.1.2. Industry Evolution/Developments
? ? 4.2. Overview
? ? 4.3. Market Dynamics
? ? ? ? 4.3.1. Drivers
? ? ? ? 4.3.2. Restraints
? ? ? ? 4.3.3. Opportunities
? ? 4.4. Global HER2 Antibodies Market Analysis and Forecast, 2020-2034

5. Key Insights
? ? 5.1. Pipeline Analysis
? ? 5.2. Key Product/Brand Analysis
? ? 5.3. Key Mergers & Acquisitions
? ? 5.4. COVID-19 Pandemic Impact on Industry

6. Global HER2 Antibodies Market Analysis and Forecast, by Type of Treatment Drugs
? ? 6.1. Introduction & Definition
? ? 6.2. Key Findings/Developments
? ? 6.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 6.3.1. Trastuzumab
? ? ? ? 6.3.2. Lapatinib
? ? ? ? 6.3.3. Ado-trastuzumab Emtansine
? ? ? ? 6.3.4. Pertuzumab
? ? ? ? 6.3.5. Everolimus
? ? 6.4. Market Attractiveness Analysis, by Type of Treatment Drugs

7. Global HER2 Antibodies Market Analysis and Forecast, by Region
? ? 7.1. Key Findings
? ? 7.2. Market Value Forecast, by Region, 2020-2034
? ? ? ? 7.2.1. North America
? ? ? ? 7.2.2. Europe
? ? ? ? 7.2.3. Asia Pacific
? ? ? ? 7.2.4. Latin America
? ? ? ? 7.2.5. Middle East & Africa
? ? 7.3. Market Attractiveness Analysis, by Region

8. North America HER2 Antibodies Market Analysis and Forecast
? ? 8.1. Introduction
? ? 8.2. Key Findings
? ? 8.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 8.3.1. Trastuzumab
? ? ? ? 8.3.2. Lapatinib
? ? ? ? 8.3.3. Ado-trastuzumab Emtansine
? ? ? ? 8.3.4. Pertuzumab
? ? ? ? 8.3.5. Everolimus
? ? 8.4. Market Value Forecast, by Country, 2020-2034
? ? ? ? 8.4.1. U.S.
? ? ? ? 8.4.2. Canada
? ? 8.5. Market Attractiveness Analysis
? ? ? ? 8.5.1. By Type of Treatment Drugs
? ? ? ? 8.5.2. By Country

9. Europe HER2 Antibodies Market Analysis and Forecast
? ? 9.1. Introduction
? ? 9.2. Key Findings
? ? 9.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 9.3.1. Trastuzumab
? ? ? ? 9.3.2. Lapatinib
? ? ? ? 9.3.3. Ado-trastuzumab Emtansine
? ? ? ? 9.3.4. Pertuzumab
? ? ? ? 9.3.5. Everolimus
? ? 9.4. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 9.4.1. Germany
? ? ? ? 9.4.2. U.K.
? ? ? ? 9.4.3. France
? ? ? ? 9.4.4. Italy
? ? ? ? 9.4.5. Spain
? ? ? ? 9.4.6. Rest of Europe
? ? 9.5. Market Attractiveness Analysis
? ? ? ? 9.5.1. By Type of Treatment Drugs
? ? ? ? 9.5.2. By Country/Sub-region

10. Asia Pacific HER2 Antibodies Market Analysis and Forecast
? ? 10.1. Introduction
? ? 10.2. Key Findings
? ? 10.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 10.3.1. Trastuzumab
? ? ? ? 10.3.2. Lapatinib
? ? ? ? 10.3.3. Ado-trastuzumab Emtansine
? ? ? ? 10.3.4. Pertuzumab
? ? ? ? 10.3.5. Everolimus
? ? 10.4. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 10.4.1. China
? ? ? ? 10.4.2. Japan
? ? ? ? 10.4.3. India
? ? ? ? 10.4.4. Australia & New Zealand
? ? ? ? 10.4.5. Rest of Asia Pacific
? ? 10.5. Market Attractiveness Analysis
? ? ? ? 10.5.1. By Type of Treatment Drugs
? ? ? ? 10.5.2. By Country/Sub-region

11. Latin America HER2 Antibodies Market Analysis and Forecast
? ? 11.1. Introduction
? ? 11.2. Key Findings
? ? 11.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 11.3.1. Trastuzumab
? ? ? ? 11.3.2. Lapatinib
? ? ? ? 11.3.3. Ado-trastuzumab Emtansine
? ? ? ? 11.3.4. Pertuzumab
? ? ? ? 11.3.5. Everolimus
? ? 11.4. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 11.4.1. Brazil
? ? ? ? 11.4.2. Mexico
? ? ? ? 11.4.3. Rest of Latin America
? ? 11.5. Market Attractiveness Analysis
? ? ? ? 11.5.1. By Type of Treatment Drugs
? ? ? ? 11.5.2. By Country/Sub-region

12. Middle East & Africa HER2 Antibodies Market Analysis and Forecast
? ? 12.1. Introduction
? ? 12.2. Key Findings
? ? 12.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
? ? ? ? 12.3.1. Trastuzumab
? ? ? ? 12.3.2. Lapatinib
? ? ? ? 12.3.3. Ado-trastuzumab Emtansine
? ? ? ? 12.3.4. Pertuzumab
? ? ? ? 12.3.5. Everolimus
? ? 12.4. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 12.4.1. GCC Countries
? ? ? ? 12.4.2. South Africa
? ? ? ? 12.4.3. Rest of Middle East & Africa
? ? 12.5. Market Attractiveness Analysis
? ? ? ? 12.5.1. By Type of Treatment Drugs
? ? ? ? 12.5.2. By Country/Sub-region

13. Competition Landscape
? ? 13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
? ? 13.2. Market Share Analysis, by Company (2023)
? ? 13.3. Company Profiles
? ? ? ? 13.3.1. Novartis AG
? ? ? ? ? ? 13.3.1.1. Company Overview
? ? ? ? ? ? 13.3.1.2. Product Portfolio
? ? ? ? ? ? 13.3.1.3. SWOT Analysis
? ? ? ? ? ? 13.3.1.4. Financial Overview
? ? ? ? ? ? 13.3.1.5. Strategic Overview
? ? ? ? 13.3.2. Pfizer, Inc.
? ? ? ? ? ? 13.3.2.1. Company Overview
? ? ? ? ? ? 13.3.2.2. Product Portfolio
? ? ? ? ? ? 13.3.2.3. SWOT Analysis
? ? ? ? ? ? 13.3.2.4. Financial Overview
? ? ? ? ? ? 13.3.2.5. Strategic Overview
? ? ? ? 13.3.3. F. Hoffmann-La Roche Ltd.
? ? ? ? ? ? 13.3.3.1. Company Overview
? ? ? ? ? ? 13.3.3.2. Product Portfolio
? ? ? ? ? ? 13.3.3.3. SWOT Analysis
? ? ? ? ? ? 13.3.3.4. Financial Overview
? ? ? ? ? ? 13.3.3.5. Strategic Overview
? ? ? ? 13.3.4. Abnova Corporation
? ? ? ? ? ? 13.3.4.1. Company Overview
? ? ? ? ? ? 13.3.4.2. Product Portfolio
? ? ? ? ? ? 13.3.4.3. SWOT Analysis
? ? ? ? ? ? 13.3.4.4. Financial Overview
? ? ? ? ? ? 13.3.4.5. Strategic Overview
? ? ? ? 13.3.5. InvivoGen
? ? ? ? ? ? 13.3.5.1. Company Overview
? ? ? ? ? ? 13.3.5.2. Product Portfolio
? ? ? ? ? ? 13.3.5.3. SWOT Analysis
? ? ? ? ? ? 13.3.5.4. Financial Overview
? ? ? ? ? ? 13.3.5.5. Strategic Overview
? ? ? ? 13.3.6. Celltrion, Inc.
? ? ? ? ? ? 13.3.6.1. Company Overview
? ? ? ? ? ? 13.3.6.2. Product Portfolio
? ? ? ? ? ? 13.3.6.3. SWOT Analysis
? ? ? ? ? ? 13.3.6.4. Financial Overview
? ? ? ? ? ? 13.3.6.5. Strategic Overview
? ? ? ? 13.3.7. Biocon
? ? ? ? ? ? 13.3.7.1. Company Overview
? ? ? ? ? ? 13.3.7.2. Product Portfolio
? ? ? ? ? ? 13.3.7.3. SWOT Analysis
? ? ? ? ? ? 13.3.7.4. Financial Overview
? ? ? ? ? ? 13.3.7.5. Strategic Overview
? ? ? ? 13.3.8. Novus Biologicals
? ? ? ? ? ? 13.3.8.1. Company Overview
? ? ? ? ? ? 13.3.8.2. Product Portfolio
? ? ? ? ? ? 13.3.8.3. SWOT Analysis
? ? ? ? ? ? 13.3.8.4. Financial Overview
? ? ? ? ? ? 13.3.8.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global HER2 Antibodies Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global HER2 Antibodies Market Revenue (US$ Mn), by Type of Treatment Drugs, 2023

Figure 03: Global HER2 Antibodies Market Value Share, by Type of Treatment Drugs, 2023

Figure 04: Global HER2 Antibodies Market Value Share, by Region, 2023

Figure 05: Global HER2 Antibodies Market Value (US$ Mn) Forecast, 2024-2034

Figure 06: Global HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 07: Global HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

Figure 08: Global HER2 Antibodies Market Value Share Analysis, by Region, 2023 and 2034

Figure 09: Global HER2 Antibodies Market Attractiveness Analysis, by Region, 2023-2034

Figure 10: North America HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 11: North America HER2 Antibodies Market Attractiveness Analysis, by Country, 2024-2034

Figure 12: North America HER2 Antibodies Market Value Share Analysis, by Country, 2023 and 2034

Figure 13: North America HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 14: North America HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

Figure 15: Europe HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 16: Europe HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 17: Europe HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 18: Europe HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 19: Europe HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

Figure 20: Asia Pacific HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 21: Asia Pacific HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 22: Asia Pacific HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 23: Asia Pacific HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 24: Asia Pacific HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

Figure 25: Latin America HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 26: Latin America HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 27: Latin America HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 28: Latin America HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 29: Latin America HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

Figure 30: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 31: Middle East & Africa HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 32: Middle East & Africa HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 33: Middle East & Africa HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034

Figure 34: Middle East & Africa HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034

List of Tables

List of Tables

Table 01: Global HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034

Table 02: Global HER2 Antibodies Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 03: North America HER2 Antibodies Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 04: North America HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034

Table 05: Europe HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 06: Europe HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034

Table 07: Asia Pacific HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 08: Asia Pacific HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034

Table 09: Latin America HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Latin America HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034

Table 11: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 12: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034